The transcatheter implantation of prosthetic aortic valves is expanding
extremely rapidly across the UK. This is a technology in the early
stages of evolution, and for which there are currently few data on
medium and long term outcomes. It is a technology with enormous
potential, and there seems little doubt that it will play an important
part in the treatment of aortic stenosis in frail patients unsuitable
for conventional surgical aortic valve replacement.
The British Cardiovascular Intervention Society (BCIS) and the Society of Cardiothoracic Surgeons (SCTS) have produced a dataset for TAVI, and it is intended that all units implanting transcatheter aortic valves will complete this dataset for each procedure. Further information on the dataset is available here:
National Institute for Health and Clinical Excellence (NICE) guidance published in June 2008 (IPG 266) supports appropriate use of TAVI, and suggests all procedures should be recorded in a national database.
Further information, from NICE, is available by following these links:
If you have any enquiries about TAVI, please contact:
- TAVI ENQUIRIES (click to email)
Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. More...
Published: Jan 18, 2012 11:34:24 AM
Published: May 17, 2011 4:23:47 PM
Page last modified on 12 apr 13 14:21